InsidersTradesSigma
Follow the XSpray Pharma AB (publ) stock price and the full directors' dealings record of the company, a listed equity based in Finland. Shares are listed on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, XSpray Pharma AB (publ) has published 1 insider filings. The latest transaction was disclosed on 20 August 2026 (Purchase). Among the most active insiders: Anders Bladh, Ribbskottet. All data is accessible without an account.
1
Insider Decl.
n/a
Thresholds
€3,486
1 ops.
Buy Volume
n/a
n/a
Sell Volume
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 20 August 2026
Declarations1 total
3,690 shares@ SEK 10.50AktieISIN SE0009973563FI:csv-4cff0ba90170591afe25
1 of 1 declaration
Acerca de XSpray Pharma AB (publ)
XSpray Pharma AB (publ) es una empresa farmacéutica centrada en el desarrollo de tratamientos innovadores para enfermedades oncológicas. Cotiza en el mercado XSTO.